Cyclodextrin based novel drug delivery systems

被引:331
作者
Vyas, Amber [1 ]
Saraf, Shailendra [1 ]
Saraf, Swarnlata [1 ]
机构
[1] Pt Ravishankar Shukla Univ, Inst Pharm, Raipur 492010, Chhattisgarh, India
关键词
cyclodextrin; complexed; novel drug delivery; liposomes; beads; nanosponges; nanogels/nanoassemblies; nanoparticles; hydrogels;
D O I
10.1007/s10847-008-9456-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The versatile pharmaceutical material cyclodextrin's (CDs) are classified into hydrophilic, hydrophobic, and ionic derivatives. By the early 1950s the basic physicochemical characteristics of cyclodextrins had been discovered, since than their use is a practical and economical way to improve the physicochemical and pharmaceutical properties such as solubility, stability, and bioavailability of administered drug molecules. These CDs can serve as multi-functional drug carriers, through the formation of inclusion complex or the form of CD/drug conjugate and, thereby potentially serving as novel drug carriers. This contribution outlines applications and comparative benefits of use of cyclodextrins (CDs) and their derivatives in the design of novel delivery systems like liposomes, microspheres, microcapsules, nanoparticles, cyclodextrin grafted cellulosic fabric, hydrogels, nanosponges, beads, nanogels/nanoassemblies and cyclodextrin-containing polymers. The article also focuses on the ability of CDs to enhance the drug absorption across biological barriers, the ability to control the rate and time profiles of drug release, drug safety, drug stability, and the ability to deliver a drug to targeted site. The article highlight's on needs, limitations and advantages of CD based delivery systems. CDs, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.
引用
收藏
页码:23 / 42
页数:20
相关论文
共 188 条
[1]  
Ahn HJ, 1997, DRUG DEV IND PHARM, V23, P397
[2]   Improved efficacy and tolerability of retinoic acid in acne vulgaris:: a new topical formulation with cyclodextrin complex ψ [J].
Anadolu, RY ;
Sen, T ;
Tarimci, N ;
Birol, A ;
Erdem, C .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (04) :416-421
[3]   FORMATION, BIOAVAILABILITY AND ORGANOLEPTIC PROPERTIES OF AN INCLUSION COMPLEX OF FEMOXETINE WITH BETA-CYCLODEXTRIN [J].
ANDERSEN, FM ;
BUNDGAARD, H ;
MENGEL, HB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (01) :51-60
[4]   Study of omeprazole-γ-cyclodextrin complexation in the solid state [J].
Arias, MJ ;
Moyano, JR ;
Muñoz, P ;
Ginés, JM ;
Justo, A ;
Giordano, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (03) :253-259
[5]   Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats [J].
Arima, H ;
Yunomae, K ;
Miyake, K ;
Irie, T ;
Hirayama, F ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (06) :690-701
[6]  
ASKRABIC JM, 1997, DRUG DEV IND PHARM, V23, P1123
[7]   Microencapsulation of cinnamon leaf (Cinnamomum zeylanicum) and garlic (Allium sativum) oils in β-cyclodextrin [J].
Ayala-Zavala, J. Fernando ;
Soto-Valdez, Herlinda ;
Gonzalez-Leon, Alberto ;
Alvarez-Parrilla, Emilio ;
Martin-Belloso, Olga ;
Gonzalez-Aguilar, Gustavo A. .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2008, 60 (3-4) :359-368
[8]   Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin [J].
Babu, RJ ;
Pandit, JK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) :155-165
[9]   Effect of aging on the dissolution stability of glibenclamide/β-cyclodextrin complex [J].
Babu, RJ ;
Pandit, JK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (11) :1215-1219
[10]   Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins [J].
Becket, G ;
Schep, LJ ;
Tan, MY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (01) :65-71